Format

Send to:

Choose Destination
See comment in PubMed Commons below
Clin Pharmacol Ther. 2013 Jun;93(6):474-5. doi: 10.1038/clpt.2013.60.

Advancing the science of pharmacovigilance.

Author information

  • 1honigpk@hotmail.com

Abstract

The importance of detecting postmarketing safety signals earlier and with a high degree of fidelity is increasingly important and of great interest to industry, regulators, and the public. This issue of Clinical Pharmacology & Therapeutics contains two companion articles that represent exciting new advances in the field of pharmacovigilance and postmarketing safety signal detection. Given that drug safety evaluation and pharmacovigilance science are core competencies in the discipline of clinical pharmacology, these articles should be of interest to clinical pharmacologists as well as drug safety professionals.

PMID:
23689213
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for John Wiley & Sons, Inc.
    Loading ...
    Write to the Help Desk